Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
0.9%
1w
1.3%
1m
6.9%
3m
21.6%
6m
15.6%
1y
25.8%
all
17.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 780 0.9%
743
1,014
Company Overview
Sales
830 Cr
Growth: 18.2%
Profit after Tax
67.3 Cr
Growth: 3.3%
Small Cap
1,645 Cr
P/E: 24.5x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 830
Growth 18.2%
EBITDA 12.7%
P/S 2.0x
Dividend 0.6%
P/E 24.5x
Book Value ₹ 257
PEG Ratio 1.3x
ROE 13.0%
P/B 3.0x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (3)
ajay.kum...
ravi036
jainam.b...
Followers (1)
varsha96